NCT04160195 2022-02-15T Cells Expressing Fully-human Anti-CD19 and Anti-CD20 Chimeric Antigen Receptors for Treating B-cell Malignancies and Hodgkin LymphomaNational Institutes of Health Clinical Center (CC)Phase 1 Terminated2 enrolled 14 charts